Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleImaging

Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with 177Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy

Aadil Adnan and Sandip Basu
Journal of Nuclear Medicine Technology March 2020, 48 (1) 36-39; DOI: https://doi.org/10.2967/jnmt.119.227058
Aadil Adnan
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, and Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Basu
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, and Homi Bhabha National Institute, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 48 no. 1 36-39
DOI 
https://doi.org/10.2967/jnmt.119.227058
PubMed 
31401619

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication January 31, 2019
  • Accepted for publication June 3, 2019
  • Published online March 6, 2020.

Article Versions

  • previous version (August 10, 2019 - 09:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Aadil Adnan and
  2. Sandip Basu
  1. Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, and Homi Bhabha National Institute, Mumbai, India
  1. For correspondence or reprints contact: Sandip Basu, Radiation Medicine Centre (BARC), Tata Memorial Hospital Annexe, Homi Bhabha National Institute, Jerbai Wadia Rd., Dadar East, Mumbai, Maharashtra 400012, India. E-mail: drsanb{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE
    Luca Urso, Alberto Nieri, Licia Uccelli, Angelo Castello, Paolo Artioli, Corrado Cittanti, Maria Cristina Marzola, Luigia Florimonte, Massimo Castellani, Sergio Bissoli, Francesca Porto, Alessandra Boschi, Laura Evangelista, Mirco Bartolomei
    Pharmaceutics 2023 15 4
  • VIPoma: Mechanisms, clinical presentation, diagnosis and treatment (Review)
    Leila Abdullayeva
    World Academy of Sciences Journal 2019

Article usage

Article usage: August 2019 to April 2025

AbstractFullPdf
Aug 201914002
Sep 201910705
Oct 20197000
Nov 20196401
Dec 20194600
Jan 20203300
Feb 20206103
Mar 202019626
Apr 202019707
May 202014705
Jun 20208401
Jul 20205800
Aug 20206421
Sep 20205411
Oct 20207607
Nov 20204804
Dec 20203913
Jan 20214402
Feb 20215601
Mar 2021341411
Apr 2021161613
May 2021191913
Jun 202118104
Jul 20212499
Aug 202125175
Sep 20211895
Oct 2021332028
Nov 2021201622
Dec 2021352614
Jan 202222156
Feb 202219206
Mar 2022142612
Apr 202210128
May 2022141113
Jun 202251212
Jul 202211176
Aug 2022112012
Sep 2022132016
Oct 202213218
Nov 20229144
Dec 202214225
Jan 202312173
Feb 202312248
Mar 20237319
Apr 2023132316
May 2023102212
Jun 20232176
Jul 20238148
Aug 202392110
Sep 20234174
Oct 202313237
Nov 20236299
Dec 20235229
Jan 20248534
Feb 20248154
Mar 20249169
Apr 2024133413
May 202465516
Jun 202415217
Jul 2024104617
Aug 2024164822
Sep 2024183824
Oct 2024104322
Nov 2024252911
Dec 2024141911
Jan 202573828
Feb 2025135517
Mar 2025206128
Apr 2025156144
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 48 (1)
Journal of Nuclear Medicine Technology
Vol. 48, Issue 1
March 1, 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with 177Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with 177Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy
Aadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology Mar 2020, 48 (1) 36-39; DOI: 10.2967/jnmt.119.227058

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with 177Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy
Aadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology Mar 2020, 48 (1) 36-39; DOI: 10.2967/jnmt.119.227058
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE I
    • CASE II
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early 10-Minute Postinjection [18F]F-FAPI-42 uEXPLORER Total-Body PET/CT Scanning Protocol for Staging Lung Cancer Using HYPER Iterative Reconstruction
  • Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate
  • Software Discrepancies in Radionuclide-Derived Left Ventricular Ejection Fraction
Show more Imaging

Similar Articles

Keywords

  • 177Lu-DOTATATE
  • neuroendocrine tumor
  • Peptide Receptor Radionuclide Therapy
  • primary soft tissue neuroendocrine tumor
SNMMI

© 2025 SNMMI

Powered by HighWire